GEN Exclusives

More »

GEN News Highlights

More »
Oct 16, 2006

Tris Pharma Expands Facilities

  • Tris Pharma unveiled a new research and manufacturing facility at its South Brunswick, NJ campus. The 30,000-sq-ft expansion adds a cGMP facility.

    “This facility enhances our manufacturing capabilities and also enables us to continue to invest in our drug development,” says Ketan Mehta, CEO and founder. “This is the final piece of the puzzle for our first phase of growth and keeps our operations scalable to keep pace with several more deals and new technologies in the pipeline.”

    The company reports that it can now provide its partners clinical supplies, submission batches, eCTD filing, and medium-scale commercial production of tablets, capsules, liquid suspensions, and oral solutions, and packaging for the finished products.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

New Drugs for Ebola

Do you think that biopharma companies should not have to go through the normal drug approval process in order to get potential life-saving therapies to Ebola patients more quickly?